# Vancomycin vs. Vancomycin Plus Gentamycin in Treatment of MRSA Infection

> **NCT00304811** · PHASE4 · COMPLETED · sponsor: **Michael E. DeBakey VA Medical Center** · enrollment: 160 (estimated)

## Conditions studied

- Staphylococcus Aureus

## Interventions

- **DRUG:** Vancomycin
- **DRUG:** Vancomycin plus Gentamicin
- **DRUG:** Vancomycin plus Rifampin
- **DRUG:** Vancomycin plus Gentamicin plus Rifampin

## Key facts

- **NCT ID:** NCT00304811
- **Lead sponsor:** Michael E. DeBakey VA Medical Center
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2007-01
- **Final completion:** 2007-01
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2009-09-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00304811

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00304811, "Vancomycin vs. Vancomycin Plus Gentamycin in Treatment of MRSA Infection". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00304811. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*